Prostaglandins

3.9k papers and 97.8k indexed citations i.

About

The 3.9k papers published in Prostaglandins in the last decades have received a total of 97.8k indexed citations. Papers published in Prostaglandins usually cover Pharmacology (1.6k papers), Physiology (810 papers) and Molecular Biology (806 papers) specifically the topics of Inflammatory mediators and NSAID effects (1.5k papers), Eicosanoids and Hypertension Pharmacology (667 papers) and Estrogen and related hormone effects (539 papers). The most active scholars publishing in Prostaglandins are Salvador Moncada, John R. Vane, Stuart Bunting, William S. Powell, Robert R. Gorman, Ryszard J. Gryglewski, A.I. Csapo, Lawrence G. Raisz, John A. Salmon and Meire Nakamura.

In The Last Decade

Fields of papers published in Prostaglandins

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Prostaglandins. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Prostaglandins

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Prostaglandins. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Prostaglandins with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025